Background: Sepsis is an important cause of disease and death worldwide, and it has a complex and heterogeneous disease process. It is now recognized that biological markers improve sepsis classification and may facilitate the identification of different subclasses or endotypes of patients. Objective: To analyze the current concepts in translational biology that help to understand the heterogeneity in the response of the patient with sepsis. Conclusions: There are a number of biomarkers that could be useful for constructing endo-compound types that predict uncomplicated results in sepsis. These endotypes could help identify patients who deserve early antimicrobial onset or discontinuation.
CITATION STYLE
Godínez-Vidal, A. R., Carrillo-Esper, R., & Cabello-Aguilera, R. (2021). Biomarcadores y endotipos en la sepsis. Nuevas evidencias. Cirugía y Cirujanos, 89(4). https://doi.org/10.24875/ciru.20001734
Mendeley helps you to discover research relevant for your work.